Detection of Babesia equi in infected horses and carrier animals using a DNA probe.

This study explores the potential of Babesia equi DNA probes, namely pSE2 and pSB20, in recognizing the presence of parasites in the blood of infected horses and carriers. The research reveals that these probes can sensitively monitor parasite level and detect Babesia equi DNA even in cases with relatively low levels of parasitaemia, making them effective for laboratory-based tests.

Methodology and Clinical Monitoring

During this research, blood tests were conducted on horses that were naturally infected, experimentally infected, and known carriers of Babesia equi parasites. The two DNA probes being tested, pSE2 and pSB20, were used in a hybridization assay on the blood samples. The horses’ clinical statuses were continually monitored during this period using a variety of methods, including:

• Microscopy to visualize the parasites,
• Indirect fluorescent antibody tests for detecting antibodies,
• Packed cell volume calculations for the proportion of horse blood volume made up by red blood cells,
• Monitoring of the horses’ body temperatures,
• And the probe assay itself to track parasite levels.

Probes’ Performance and Sensitivity

Data obtained from the studies revealed excellent performance by the DNA probes in monitoring the levels of Babesia equi. As the horses’ disease developed, the probes’ readings correlated well with the other methods of monitoring used, providing an effective means to track the progression of the parasitic infection. Remarkably, these probes demonstrated superior sensitivity compared to traditional light microscopy, detecting parasitaemia levels equivalent to less than 0.0025% – a significantly low amount that could easily go undetected with other methods.

Detection of Babesia equi DNA

The B. equi DNA probes were successful in detecting the presence of parasites in all naturally infected cases studied in this research. Additionally, out of 119 randomly chosen horses, 20 were flagged by the probes as carriers of B. equi parasites—an impressive figure considering that only 8 of these could be identified as carriers through microscopy. This difference underscores the increased sensitivity of the DNA probes.

Conclusions and Future Applications

The results of the research demonstrate the efficacy and sensitivity of Babesia equi repetitive probes pSE2 and pSB20 in detecting and tracking parasite levels in both infected horses and carriers. Given their performance, these probes were deemed suitable for use in a routine laboratory-based assay for B. equi. Their sensitivity, superior to that of light microscopy, positions them as a significantly useful tool in diagnosing and monitoring B. equi infections. This discovery could markedly enhance detection and treatment strategies for equine babesiosis in the future.